Delivery Order SPE2DB24D2101-SPE2DB25FKKAA
Award Date
4/29/25
Potential Completion Date
4/30/25
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order worth $34,232.81 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Firm Fixed Price contract, which has an ultimate completion date of December 20, 2024, is for the delivery of 4566771042 - PROLIA 60 MG/ML SYRINGEML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a $16,071.75 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Prolia 60 mg/ml syringes, a specialty medication used for treating certain medical conditions. The contract has an ultimate completion date of March 14, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,975.84, is for the delivery of PROLIA 60 MG/ML SYRINGEML, a prescription medication. The contract is not set aside and is a firm fixed-price, delivery order. It has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $21,845.19, is for the supply of Prolia 60 mg/ml syringes. There is no set-aside designation mentioned. The contract has an ultimate completion date of September 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,071.45, is for the supply of Prolia 60 mg/ml syringes. It is a Firm Fixed Price contract with a completion date of February 14, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes. The contract has a firm fixed price of $10,955.46 and an ultimate completion date of February 20, 2025. The contract is not designated as a set-aside and is an open competition award. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products, including prescription drugs, vaccines, and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,620.86, is for the supply of Prolia 60 mg/mL syringes. It is a firm fixed-price contract with a period of performance through July 14, 2022. The contract was not set aside for any specific business category. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,428.70, is for the delivery of Prolia 60 mg/ml syringes. It is a firm fixed-price delivery order contract with an ultimate completion date of April 3, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $21,200.83 contract is for the supply of Prolia 60 mg/ml syringes, with a completion date of February 6, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 and a performance period...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,502.85, is for the procurement of Prolia 60 mg/ml syringes. The award has an ultimate completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...